Trial results
AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
According to the results reported on ClinicalTrials.gov, this trial (NCT02709694) enrolled 33 adults with Crohn's disease, and all 33 completed the study. The trial was measuring how often a type of joint inflammation called sacroiliitis — inflammation of the joints where the spine meets the pelvis — could be detected on MRI scans in people with Crohn's disease, and whether that related to whether they had back pain. Participants were grouped into those who reported any back pain (19 people) and those who did not (14 people). The scans were reviewed by three specialist doctors using several different methods to assess for signs of inflammation and structural changes in the joints. The reported data shows that, using the main "global assessment" scoring method (where at least two out of three reviewing doctors had to agree), 4 out of 19 people in the back pain group had MRI results considered positive for sacroiliitis, while none of the 14 people in the no-back-pain group did. Using a different scoring approach called "Morpho" (based on detecting bone swelling and/or erosion on the scan), 5 people in the back pain group and 1 in the no-back-pain group were recorded as positive. A third method called "SPACE" (based on erosion and fatty changes) found zero positive results in either group. For a secondary measure, 13 out of 19 people in the back pain group were recorded as meeting criteria for a related spinal condition called axial spondyloarthritis. The reported data also shows that 14 people in the back pain group and 4 in the no-back-pain group had current joint pain in other parts of the body (peripheral arthritis). These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.
View full results on ClinicalTrials.gov ↗ · Read the linked publication on PubMed (PMID 15825070) ↗
These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.
Crohn's Disease and Colitis Trial, Completed
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- You have been diagnosed with Crohn's Disease confirmed by a biopsy.
- You either do or do not have back pain that is related to inflammation (the trial is looking for a mix of both groups).
- You are 18 years old or older.
- You speak English.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- You have a history of psoriasis or another type of inflammatory joint condition.
- You have taken a biologic medication (a type of specialist drug used to treat immune conditions) in the past six months, unless it was Vedolizumab specifically.
- You are unable to have an MRI scan for any medical reason.
- You have had cancer in the last 5 years, unless it was a type of non-melanoma skin cancer and it is in remission.
- You do not speak English.
- You are not able to follow the study's required schedule or instructions.
- You are critically or terminally ill.
- You are pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
If this is close to home
This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.
- Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
- Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
- Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
- Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
- Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14
Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.
Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.
Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial was run
These are the locations recorded on the registry, and they are a historical record: this trial is not enrolling, so they are not places you can join it.
Primary endpoints
Number of Participants With MRI Positivity- Global Assessment Positive; Number of Participants With MRI Positivity- ASAS Positive; Number of Participants With MRI Positivity- SPACE Positive; Number of Participants With MRI Positivity- Morpho Positive
Other options
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.